Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial-Reference-Cited by-同舟云学术

Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial

Published:2014-07-28 Issue:3 Volume:167 Page:327-336
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Pardal Emilia¹,Coronado Mónica²,Martín Alejandro³,Grande Carlos⁴,Marín-Niebla Ana⁵,Panizo Carlos⁶,Bello José Luis⁷,Conde Eulogio⁸,Hernández Miguel T.⁹,Arranz Reyes¹⁰,Bargay Joan¹¹,González-Barca Eva¹²,Pérez-Ceballos Elena¹³,Montes-Moreno Santiago¹⁴,Caballero María Dolores³

Affiliation:

1. Department of Haematology; Hospital Virgen del Puerto; Plasencia Spain

2. Department of Nuclear Medicine; Hospital Universitario La Paz; Madrid Spain

3. Department of Haematology; Hospital Universitario de Salamanca-IBSAL; Salamanca Spain

4. Department of Haematology; Hospital Universitario 12 de Octubre; Madrid Spain

5. Department of Haematology; Hospital Universitario Virgen del Rocío; IBIS/CSIC/Universidad de Sevilla; Sevilla Spain

6. Department of Haematology; Clínica Universitaria de Navarra; Pamplona Spain

7. Department of Haematology; Complejo Hospitalario Universitario de Santiago; Universidad de Santiago de Compostela; Santiago de Compostela Spain

8. Department of Haematology; Hospital Marqués de Valdecilla; Universidad de Cantabria; Santander Spain

9. Department of Haematology; Hospital Universitario de Canarias; Santa Cruz de Tenerife Spain

10. Department of Haematology; Hospital de La Princesa; Madrid Spain

11. Department of Haematology; Hospital Son Llàtzer; Palma de Mallorca Spain

12. Department of Haematology; Institut Catalá d‘Oncologia; Hospital Duran i Reynals; L'Hospitalet de LLobregat Spain

13. Department of Haematology; Hospital General Universitario Morales Meseguer; Murcia Spain

14. Department of Pathology; Hospital Universitario Marqués de Valdecilla; IFIMAV; Santander Spain

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13036/fullpdf

Reference43 articles.

1. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in high-risk aggressive B-cell lymphoma: a prospective study from the GEL/TAMO study group;Arranz;European Journal of Haematology,2008

2. Dose-intense chemotherapy every 2 weeks with dose intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate-and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349);Blayney;Journal of Clinical Oncology,2003

3. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors;Caballero;Bone Marrow Transplantation,1997

4. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group;Caballero;Annals of Oncology,2003

5. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma;Casasnovas;Blood,2011

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement;Hematological Oncology;2024-03

2. Значение ПЭТ, совмещенной с КТ, при диффузной В-крупноклеточной лимфоме: история вопроса, эволюция представлений и современные возможности метода (обзор литературы);Clinical Oncohematology;2024-02-20

3. 中期PET-CT在淋巴瘤一线治疗决策中的应用;Journal of Zhejiang University-SCIENCE B;2023-10

4. PET/CT in Non-Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05

5. PET/CT in Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05